Compound Heterozygous Sickle Cell-β-Thalassemia: A Case Report from Upper Assam, India
Anju Barhai Teli, Rumi Deori, Sidhartha Protim Saikia and 1 more
National Journal of Laboratory Medicine · 2016
doi:10.7860/njlm/2016/19216:2115 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Sickle cell-β-thalassemia [Hb S/β- thalassemia] is a rare type of hemoglobinopathy. The clinical characteristics of Hb S/β- thalassemia are highly variable from a completely asymptomatic state to a severe disorder like homozygous sickle cell disease. In India IVS I-5 (G→C) is the most common β-thalassemia allele. In this study we presented a case of compound heterozygous Hb S/β- thalassemia in a 14-year-old female with complaints of anemia with weakness, joint pain and splenomegaly. The patient and her parents were diagnosed by HPLC and for detection of mutational pattern of β-thalassemia; ARMS-PCR and DNA sequencing were performed. The HPLC report suggested that the patient have Hb S/β- thalassemia and molecular diagnosis confirmed that the patient inherited IVS I-5 (G→C) β- thalassemia mutation.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.